Eli Lilly and Co. has won the unanimous backing of an advisory panel to introduce the first rival to the blood-thinner Plavix, the world’s No. 2-selling drug, Bloomberg News reported. Advisers to the U.S. Food and Drug Administration voted 9-0 today in Silver Spring, Md., that Lilly’s blood thinner prasugrel should be approved to reduce […]
A panel of government health experts yesterday said a highly anticipated Eli Lilly and Co. blood thinner marks a significant advance over older treatments and should be approved. The nine members of the Food and Drug Administration’s cardiology advisory group unanimously voted in favor of the company’s anti-clotting drug prasugrel, saying it should be approved […]
Federal health regulators are looking into evidence that an Eli Lilly and Co. drug used to treat blood poisoning worsens the risk of bleeding and can lead to death in certain patients. The Food and Drug Administration said today a recently published study showed that the Indianapolis-based company’s drug Xigris increased the risk of dangerous […]
Eli Lilly and Co. CEO John C. Lechleiter saw his compensation spike nearly 28 percent in 2008 as he took over the top job at the Indianapolis-based drugmaker. Lechleiter received $10.8 million in salary, bonus, stock and perks during the year, according to a preliminary proxy statement filed today by Lilly with the U.S. Securities […]
Indiana Medicaid officials want to take over management of all its patients’ prescription drugs because they say it could save the state as much as $40 million a year.
Two drug companies, Pfizer Inc. and Eli Lilly and Co., spent hundreds of millions of dollars last year to raise awareness of a murky illness, helping boost sales of pills recently approved as treatments and drowning out unresolved questions – including whether it’s a real disease at all. Key components of the industry-funded buzz over […]
Three of the world’s largest drugmakers, including Indianapolis-based Eli Lilly and Co., are being accused of fixing prices for erectile dysfunction drugs in Switzerland, according to Bloomberg News. Lilly, Pfizer Inc. and Bayer AG, rivals in the male impotence-drug market, fixed prices in Switzerland and should be punished, a panel of the Swiss Competition Commission, […]
A group of mostly local companies that made big investments to help launch Circle Centre mall soon could be asked to write off a portion of profits they agreed to redirect into the construction of Conseco Fieldhouse. The Capital Improvement Board has floated the possibility of asking the 13 investors-including Conseco, American United Life, Duke […]
Financially strapped Dow Chemical Co. acknowledges it may sell Indianapolis-based Dow AgroSciences LLC, the ag-chemicals-and-biotech firm that’s one of the biggest jewels in the city’s life sciences crown. Dow Chemical CEO Andrew Liveris said on a Feb. 3 conference call with analysts that the Midland, Mich.-based company has teams working with investment banks to evaluate […]
Financially strapped Dow Chemical Co. acknowledges it may sell Indianapolis-based Dow AgroSciences LLC, the ag-chemicals-and-biotech
firm that’s one of the biggest jewels in the city’s life sciences crown.
A group of mostly local companies that made big investments to help launch Circle Centre mall soon could be asked to write
off a portion of profits they agreed to redirect into the construction of Conseco Fieldhouse.
“Group think,” a powerful and controlling force, was present as the Capital Improvement Board built Lucas Oil Stadium and Eli Lilly and Co. developed and marketed Zyprexa.
Denmark-based NeuroSearch has signed an agreement with Indianapolis-based Eli Lilly and Co. to form a three-year drug discovery and development alliance to investigate treatments for central nervous system disorders. Lilly will spend $30 million in the next three years on the alliance. Of that amount, Lilly will pay $17 million to buy NeuroSearch stock, according […]
The Capital Improvement Board, short of cash and doing whatever it can to remain solvent, is considering asking a group of original investors in Circle Centre mall to forgive $34 million they loaned the city toward the construction of Conseco Fieldhouse back in 1997. Fair enough. The companies that invested demonstrated they were civic-minded when […]
If the Capital Improvement Board comes, hat in hand, looking for help, we trust the investing companies will carefully weigh the benefits they’ve derived from the city and its thriving downtown before delivering an answer.
European Union regulators have approved the blood thinner prasugrel, Indianapolis-based drugmaker Eli Lilly and Co. announced this morning. The European Commission granted marketing authorization for prasugrel, which will be sold in Europe under the brand name Efient. Lilly spokeswoman Carole Copeland said the drug will be launched “in the coming weeks,” with a separate rollout […]
European Union regulators have approved the blood thinner prasugrel, Indianapolis-based drugmaker Eli Lilly and Co. announced this morning. The European Commission granted marketing authorization for prasugrel, which will be sold in Europe under the brand name Efient. Lilly spokeswoman Carole Copeland said the drug will be launched “in the coming weeks,” with a separate rollout […]
A stock analyst says Eli Lilly and Co’s potential blockbuster drug prasugrel could face another Food and Drug Administration delay, Bloomberg News reported this morning. The experimental blood thinner may not receive U.S. action until the second quarter after regulators said they made a “mistake” removing a critic of the drug from an advisory panel […]
A stock analyst says Eli Lilly and Co’s potential blockbuster drug prasugrel could face another Food and Drug Administration delay, Bloomberg News reported this morning. The experimental blood thinner may not receive U.S. action until the second quarter after regulators said they made a “mistake” removing a critic of the drug from an advisory panel […]
One of Indiana’s pioneering life sciences companies is ailing badly. Bioanalytical Systems Inc. said last week it lost money for a fifth straight quarter as revenue plummeted. The West Lafayette-based company lost nearly $1.6 million in its first fiscal quarter ended Dec. 31, a loss 10 times as large as it recorded in the same […]
